The European public health and blood authorities responded to the threat posed by West Nile virus to blood safety of blood and blood components by adopting preventive measures which are defined in the EU blood legislation, professional guides of the Council of Europe and the EU WNV blood transfusion preparedness plan. The measures include the deferral of blood donors that have visited or residing in a NUTS 3 area considered to be affected (i.e. with at least one confirmed case).
The 2015 meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis was held in The Hague, the Netherlands, on 26-27 May 2015. The meeting was organised jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe for TB surveillance experts from WHO European region including European Union/European Economic Area (EU/EEA) Member States (MSs). The participants included 47 nominated contact points for TB surveillance from 42 countries, as well as experts from ECDC and WHO/Europe, WHO headquarters and country offices. In addition, experts from seven EU Enlargement Countries and from the KNCV TB Foundation (the Netherlands) attended the meeting as observers.
This meeting brought together TB experts from countries belonging to the WHO European Region and surveillance experts from EU/EEA countries to discuss the common goals of eliminating TB in Europe.
Location:Bratislava, Slovakia
Organized by:ECDC and the WHO Regional Office for Europe
This was the first regional meeting on West Nile fever real time surveillance and good practices on vector-borne diseases. The overall objective was to support the exchange of experience between EU and non-EU neighbouring countries on the surveillance of West Nile fever and the lessons learnt since 2011.
At this technical meeting, tuberculosis experts from high-incidence countries (Bulgaria, Estonia, Latvia, Lithuania and Romania) discussed ways in which ECDC can support with development and implementation of country strategies to prevent and control the disease.